The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted in favor of Pfizer Inc’s (NYSE:PFE) available data is adequate to…
Commodity prices have been behaving irrationally, according to a Goldman Sachs Group Inc. (NYSE: GS) analyst, citing further unsustainable price increases.